Patents by Inventor Michiel KALLENBERG

Michiel KALLENBERG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240127959
    Abstract: The invention relates to an apparatus for determining a temporal breast cancer risk (27). This risk is indicative of detecting cancer in a breast within a predetermined time interval after a negative breast cancer detection result that has been obtained by carrying out a breast cancer detection procedure defined by a breast cancer detection parameter. The temporal breast cancer risk (27) is determined based on a) a probability parameter (25) being indicative of a probability of having breast cancer and b) a density parameter (26) being indicative of a density-related property of breast tissue of a breast, wherein the probability parameter (25) and the density parameter (26) have been determined based on a breast image data set (24) of the woman by using an artificial intelligence. The determined risk can be used, for instance, for deciding whether a supplemental examination should be performed immediately or for defining a screening interval.
    Type: Application
    Filed: March 1, 2022
    Publication date: April 18, 2024
    Applicant: Screenpoint Medical B.V.
    Inventors: Nico Karssemeijer, Mehmet Dalmis, Alejandro Rodriguez, Natasja Jansen, Michiel Kallenberg, Jeroen Schouwenberg
  • Publication number: 20170249739
    Abstract: A method of screening a population of women for breast cancer by mammography, comprising establishing a screening schedule, conducting a screening mammography on a patient in accordance with said screening schedule to obtain a mammogram image, determining whether a cancer lesion is visually observable in said mammogram image, in the event that no cancer lesion is visually observable in said mammogram image conducting a computer image analysis of the mammogram image in which no potential cancer lesion is visually observable, said method serving to determine the risk of there being such a lesion physically present or about to arise within a screening interval, said method comprising applying to the image a statistical classifier trained to score on the basis of texture features in the image that reflect such risk.
    Type: Application
    Filed: February 26, 2016
    Publication date: August 31, 2017
    Applicant: BIOMEDIQ A/S
    Inventors: Michiel KALLENBERG, Mads NIELSEN, Martin LILLHOLM